Monoclonal Antibodies for the Depletion of Specific Subpopulations of Lymphocytes

  1. David Evered Organizer,
  2. Julie Whelm
  1. Herman Waldmann1,2,
  2. Steve Cobbold1,
  3. Shixin Qin1,
  4. Richard Benjamin1,
  5. Tony Nash1,
  6. Jane Welsh1,
  7. Georgia Tarnesby1

Published Online: 28 SEP 2007

DOI: 10.1002/9780470513484.ch13

Ciba Foundation Symposium 129 - Autoimmunity and Autoimmune Disease

Ciba Foundation Symposium 129 - Autoimmunity and Autoimmune Disease

How to Cite

Waldmann, H., Cobbold, S., Qin, S., Benjamin, R., Nash, T., Welsh, J. and Tarnesby, G. (2007) Monoclonal Antibodies for the Depletion of Specific Subpopulations of Lymphocytes, in Ciba Foundation Symposium 129 - Autoimmunity and Autoimmune Disease (eds D. Evered and J. Whelm), John Wiley & Sons, Ltd., Chichester, UK. doi: 10.1002/9780470513484.ch13

Author Information

  1. 1

    Immunology Division, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK

  2. 2

    Division of Immunology, Department of Pathology, Laboratories Block, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK

Publication History

  1. Published Online: 28 SEP 2007

ISBN Information

Print ISBN: 9780471910954

Online ISBN: 9780470513484

SEARCH

Keywords:

  • monoclonal antibodies;
  • depletion;
  • T lymphocyte subpopulation;
  • T cell subset-depleted mice;
  • anti-srbc responses

Summary

A number of rat monoclonal antibodies of the IgG2b subclass have been used to deplete mice of T lymphocyte subsets. It has been possible to produce long-term depletion where antibodies are administered to mice thymectomized in their adult life, or short-term depletion in euthymic animals. It is therefore feasible to ablate a T lymphocyte subpopulation at any stage in the course of an immune response and to examine in detail the role of a particular subset in the induction or effector phases of that response. We have used such ablative procedures to define the T cell subsets which participate in graft rejection, graft-versus-host disease, antigenic competition and antiviral and anti-self immunity and have attempted to exploit such knowledge to establish immunological tolerance in an adult animal.